How suzetrigine passes into breast milk
Treatments studied
Part of Pain clinical trials.
This study looks at how much of the study drug, suzetrigine, gets into breast milk. It helps us understand if it's safe for breastfeeding mothers and their infants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 6 weeks and 12 months after giving birth.
- Your baby was born at least 37 weeks into the pregnancy.
- You are currently breastfeeding or pumping at least 3 times a day.
- You are willing to pump regularly to keep up your milk supply.
- You agree not to feed your baby any breast milk produced after taking the study drug until the follow-up visit.
- You have not had a fever or other illness in the 14 days before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the medication etrasimod gets into breast milk after a single dose. If you are a healthy breastfeeding woman at least 12 weeks after giving birth, you may be able to help researchers understand this process. You would need to stop breastfeeding temporarily for 21 days.
This study measures how common medicines move through a breastfeeding parent’s milk and checks safety in both the parent and breastfed baby. It may help doctors use these medicines more safely while you continue breastfeeding.
This study measures how much of the drug zilucoplan passes into breast milk. Healthy nursing mothers who are already planning to stop breastfeeding can take part to help understand how the drug is processed.
This study looks at how much BRIUMVI (ublituximab) gets into breast milk. It helps understand if the drug is safe for breastfed babies whose mothers are already taking it for relapsing multiple sclerosis.
This study measures how much of the medication mirikizumab passes into breast milk when mothers take it for their approved medical condition. The goal is to understand if it's safe for breastfeeding infants when mothers are receiving this treatment.
This study checks how much of an antibiotic called fosfomycin passes into breast milk when given intravenously to healthy nursing mothers. The goal is to understand if it's safe for breastfeeding women to receive this antibiotic.
Hear when a new Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.